HackerTrans
TopNewTrendsCommentsPastAskShowJobs

alphaoverlord

no profile record

Submissions

AI for assessing heart function better than clinicians in blinded clinical trial

tctmd.com
3 points·by alphaoverlord·4 years ago·0 comments

comments

alphaoverlord
·3 years ago·discuss
I don’t think the examples shown reflect an element of critique.
alphaoverlord
·3 years ago·discuss
The nordicc trial was published last year. This is recent results, trials with 10 year followup take a long time to run.

https://www.nejm.org/doi/full/10.1056/NEJMoa2208375
alphaoverlord
·4 years ago·discuss
If you have complete AV block, a leadless pacemaker is less good than one with multiple leads, since it allows pacing multiple chambers and maintaining synchrony between A and V.
alphaoverlord
·5 years ago·discuss
Not all treatments are equally likely as well. Given how good dietary science is outside of cancer, less optimistic at rigorous studies in this area.
alphaoverlord
·5 years ago·discuss
It’s a research dataset, similar to MNIST or CIFAR. Stanford does not want to be in the business of monetizing patient data, so it restricts commercial use.
alphaoverlord
·5 years ago·discuss
With AIMI, we released EchoNet-Dynamic, the largest open dataset of echocardiograms (cardiac ultrasounds) and expert cardiologist labels as part of a paper published last year. The dataset went through a rigorous review to make sure no identifying information was leaked as part of the process. Happy to answer any questions.
alphaoverlord
·5 years ago·discuss
There are definitely doctors who will space it out if you’re stable or do a phone refill
alphaoverlord
·5 years ago·discuss
I have absolutely nothing against CGMs, but the author confounds measurement error (which can happen in both blood tests as well as subcutaneous measurement which a CGM does), thresholding on a population level (I doubt anyone thinks an A1c of 4.5 and 5.6 are the same), and weak evidence of impact in actual health outcomes. It’s fun in the same way a Fitbit/Apple Watch is fun, but I don’t think one should oversell it’s utility.
alphaoverlord
·5 years ago·discuss
I think number of launches was used as a proxy for number of satellites launched in the last month - more satellites/launch shouldn't impact it that much.
alphaoverlord
·10 years ago·discuss
I'm going to be a cardiology fellow at Stanford in July, we use ultrasound often for both bedside informal exams as well as diagnostic echocardiogram. I've used handheld devices like the Lumify and Vscan, as well as the large tractor sized epiq machines. Similar to what is written in the article, my impression is that the actual hardware, specifically the transducer, is quite expensive to manufacture. The software and processing power continues to get cheaper but to have to best quality pictures, require expensive transducers. I've actually been very very impressed by the Lumify and I think it is getting near if not better than the quality of the gigantic epiq machines, primarily by having a very high quality transducer. This is indeed a hot area and knowing people who are actively doing development in the field, there are poeple trying things like having a giant paralleled transducers over the entire chest for continuous 3D images and other interesting ideas that are limited more by hardware than processsing power or imagination.